Comprehensive Cancer Center Vienna – Medical University of Vienna / AKH
Austria's leading academic cancer centre at the Vienna General Hospital, known for the ABCSG breast trials, brain metastasis research and the MedAustron ion therapy centre.
The Comprehensive Cancer Center Vienna joins the Medical University of Vienna and the Vienna General Hospital (AKH), one of Europe's largest hospitals. Michael Gnant's Austrian Breast and Colorectal Cancer Study Group ran the ABCSG-12 and ABCSG-18 trials that defined adjuvant bone-targeted therapy and co-led the PALLAS trial of adjuvant palbociclib, Matthias Preusser's neuro-oncology group is a European reference for brain metastases and glioma trials, and Ulrich Jäger's haematology division leads lymphoma and CAR-T programmes. The university's radiation oncology department under Dietmar Georg provides the clinical programme at MedAustron in Wiener Neustadt, Austria's proton and carbon-ion therapy centre. The CCC also hosts the Institute of Cancer Research and a large phase 1 unit.
- Austrian Breast and Colorectal Cancer Study Group
- Brain metastases and neuro-oncology
- MedAustron proton and carbon-ion therapy
- Haematology and CAR-T
- Phase 1 unit
Pages like this
not linked directly; found by shared links- InstitutionAustrian Breast & Colorectal Cancer Study Group
Shares Breast International Group (BIG), Palbociclib, CDK4/6 inhibitors, Endocrine therapy (SERMs, AIs, SERDs).
- InstitutionEdinburgh Cancer Centre / CRUK Scotland Centre
Shares Breast International Group (BIG), CDK4/6 inhibitors, Endocrine therapy (SERMs, AIs, SERDs), Glioma & glioblastoma.
- InstitutionGEICAM Spanish Breast Cancer Group
Shares Breast International Group (BIG), Palbociclib, CDK4/6 inhibitors, Endocrine therapy (SERMs, AIs, SERDs).
- PairingCDK4/6 inhibitor + endocrine therapy
Shares Palbociclib, CDK4/6 inhibitors, Endocrine therapy (SERMs, AIs, SERDs), HR-positive / HER2-negative breast cancer.
- InstitutionKing Faisal Specialist Hospital and Research Centre
Shares Proton therapy, Diffuse large B-cell lymphoma, CAR-T cell therapy, HR-positive / HER2-negative breast cancer.
- InstitutionCleveland Clinic Abu Dhabi
Shares Proton therapy, Diffuse large B-cell lymphoma, CAR-T cell therapy, HR-positive / HER2-negative breast cancer.
- InstitutionInstitut Jules Bordet
Shares Breast International Group (BIG), EORTC, Endocrine therapy (SERMs, AIs, SERDs), Diffuse large B-cell lymphoma.
- InstitutionSOLTI Cancer Research Group
Shares Breast International Group (BIG), Palbociclib, CDK4/6 inhibitors, HR-positive / HER2-negative breast cancer.